Back to Search
Start Over
Supplemental Methods, Figures 1 - 4 from Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized Antibody
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Figure S1: Tumor free survival in humanized DKO mice. Supplemental Figure S2: T cell survival in the sc tumors. Supplemental Figure S3: Efficacy of hu3F8-BsAb vs. 5HLDS(15)BA(Y) in humanized DKO mice. Supplemental Figure S4: Cytokine release from different BsAb formats.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....131520a5c6dd2ed5360575e6754885f8